Dramatic remissions in blood cancer in immunotherapy treatment trial
Originally shared by Ward Plunet
Dramatic remissions in blood cancer in immunotherapy treatment trial
Recent advances in an immune-cell cancer treatment — a type of immunotherapy using engineered immune cells to target specific molecules on cancer cells — are producing dramatic results for people with cancer, according to Stanley Riddell, MD, an immunotherapy researcher and oncologist at Seattle’s Fred Hutchinson Cancer Research Center. Riddell and his colleagues have refined new methods of engineering a patient’s own immune cells to better target and kill cancer cells while decreasing side effects. In laboratory and clinical trials, the researchers are seeing “dramatic responses” in patients with tumors that are resistant to conventional high-dose chemotherapy, “providing new hope for patients with many different kinds of malignancies,” Riddell said.
http://www.kurzweilai.net/dramatic-remissions-in-blood-cancer-in-immunotherapy-treatment-trial
Dramatic remissions in blood cancer in immunotherapy treatment trial
Recent advances in an immune-cell cancer treatment — a type of immunotherapy using engineered immune cells to target specific molecules on cancer cells — are producing dramatic results for people with cancer, according to Stanley Riddell, MD, an immunotherapy researcher and oncologist at Seattle’s Fred Hutchinson Cancer Research Center. Riddell and his colleagues have refined new methods of engineering a patient’s own immune cells to better target and kill cancer cells while decreasing side effects. In laboratory and clinical trials, the researchers are seeing “dramatic responses” in patients with tumors that are resistant to conventional high-dose chemotherapy, “providing new hope for patients with many different kinds of malignancies,” Riddell said.
http://www.kurzweilai.net/dramatic-remissions-in-blood-cancer-in-immunotherapy-treatment-trial
Comments
Post a Comment